Recce

Recce Pharmaceuticals Ltd, located in Bentley, Western Australia, is at the forefront of developing innovative synthetic anti-infectives aimed at combating the global health crisis posed by antibiotic-resistant superbugs. Their proprietary products target both bacteria and viruses, featuring a universal mechanism of action that maintains potency even with repeated use, addressing significant medical needs in the field of infectious diseases.

The company's pipeline includes multiple clinical candidates in Phase III trials, including a registrational trial in Indonesia, showcasing a commitment to providing therapeutic options for challenging bacterial infections and their mutated forms. Recce Pharmaceuticals is dedicated to enhancing its product offerings to effectively tackle difficult infections that are resistant to existing treatments.

Generated from the website